The Supreme Court has maintained mail access to the abortion pill mifepristone, setting aside for now a lower court order ...

By Daniel Wiessner May 14 (Reuters) - The U.S. Supreme Court has for now refused to block a U.S. Food and Drug Administration rule allowing the abortion pill mifepristone to be prescribed via a ...

The court rejects an antiabortion challenge to mifepristone, an FDA-approved medication for ending early pregnancies.

The Supreme Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.

Abortion pills can remain available through the mail for the immediate future after the Supreme Court on Thursday paused a lower court ruling that would have blocked access while a lawsuit proceeds.

Nearly two-thirds of abortions in the U.S. are now induced by medication, and about one-quarter involve telemedicine.

Mifepristone, part of a two-drug regimen given to women to terminate a pregnancy, was approved by the FDA in 2000 and access ...

The Supreme Court temporarily restored access to the abortion pill mifepristone through telehealth, mail and pharmacies, blocking an appeals court ruling.

Updated on May 14 at 7:57 p.m. The Supreme Court on Thursday afternoon issued an order that continued to block a ruling by a federal appeals court in Louisiana which had barred the mailing of ...

WASHINGTON (AP) — The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues. The court’s ...